Radiofrequency ablation for colorectal liver metastases: prognostic factors in non-surgical candidates

被引:0
作者
Ayumi Hamada
Koichiro Yamakado
Atsuhiro Nakatsuka
Junji Uraki
Masataka Kashima
Haruyuki Takaki
Takashi Yamanaka
Yasuhiro Inoue
Masato Kusunoki
Kan Takeda
机构
[1] Mie University School of Medicine,Department of Radiology
[2] Mie University School of Medicine,Department of Gastrointestinal and Pediatric Surgery
来源
Japanese Journal of Radiology | 2012年 / 30卷
关键词
Radiofrequency ablation; Colorectal liver metastases; Prognostic factor;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:567 / 574
页数:7
相关论文
共 142 条
[11]  
Altendorf-Hofmann A(2010)Radiofrequency ablation in the treatment of small hepatocellular carcinoma: a meta analysis World J Gastroenterol 16 3450-3456
[12]  
Charnley RM(2010)Radiofrequency ablation for hepatocellular carcinoma: updated review in 2010 Oncology 78 113-124
[13]  
Scheele J(2008)Radiofrequency ablation of colorectal liver metastases: small size favorably predicts technique effectiveness and survival Cardiovasc Intervent Radiol 31 948-956
[14]  
Malafosse R(2001)Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients Radiology 221 159-166
[15]  
Penna C(2009)Comparative study of resection and radiofrequency ablation in the treatment of solitary colorectal liver metastases Am J Surg 197 728-736
[16]  
Sa Cunha A(2006)Solitary colorectal liver metastasis: resection determines outcome Arch Surg 141 460-466
[17]  
Nordlinger B(2005)Predictors of survival after radiofrequency thermal ablation of colorectal cancer metastases to the liver: a prospective study J Clin Oncol 23 1358-1364
[18]  
Scheele J(2009)Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation Eur Radiol 19 1206-1213
[19]  
Stang R(2007)Survival after radiofrequency ablation of colorectal liver metastases: 10-year experience Ann Surg 246 559-565
[20]  
Altendorf-Hofmann A(2010)Detection of colo-rectal liver metastases: prospective comparison of contrast enhanced US, multidetector CT, PET/CT, and 1.5 Tesla MR with extracellular and reticulo-endothelial cell specific contrast agents Abdom Imaging 35 511-521